PLANO, Texas, June 18 /PRNewswire-FirstCall/ -- AUSTIN MEDICAL TECHNOLOGIES, Inc. (OTC Pink Sheets: AMTK), dba eyeDirecti, announces the appointment of Eugene Gabianelli M.D. as the company’s “Medical Director.” Dr. Gabianelli joins Austin Medical and brings a decade of experience in Refractive Surgery (LASIK) and approximately $3 Million in new sales potential.
Currently Dr. Gabianelli is Medical Director of TLC Clear Vision Laser Center in Atlanta. He is Chief of the Division of Ophthalmology at St. Joseph’s Hospital and former member of the Georgia Society of Ophthalmology’s Leadership Council. Dr. Gabianelli has been a customer and using our Surgical Packs with success at TLC Vision Center in Atlanta for over 2 years.
http://www.austinmedtech.com/docs/BIO_Gene_Gabianelli.pdf
Kurt Tarter, President & CEO, states, “It is a real privilege to have Dr. Gabianelli become the Medical Director of AMTK. Dr. Gabianelli’s reputation and relationships within the community of ophthalmology will deliver tremendous value to our company as his insights and influence will help lead our company to greater prosperity, further enhancing shareholder value.”
Dr. Gabianelli states, “It is my pleasure to join the team at eyeDirecti as their Medical Director. I have been a customer for the past couple of years and I am very pleased with eyeDirecti’s customer service and commitment to consistently meet my unique product preferences in our custom ophthalmic surgery pack. As their Medical Director I am eager to ensure their continued success through my relationships in the community of ophthalmology.”
About Dr. Gabianelli:
Dr. Gabianelli attended Dartmouth College earning a B.S. Degree. He graduated from Washington University Medical School in St. Louis. After medical school, he completed his internship at Illinois Masonic Hospital in Chicago and was named Chief Resident during the first year of his ophthalmology residency at the University of Chicago. Following his residency, he chose a surgical fellowship in cornea, refractive, and cataract surgery with a private group in Hartford, CT. This group performed one of the first trials of laser vision surgery in the United States. After completing his fellowship, Dr. Gabianelli moved to Atlanta where he was named Medical Director for the Atlanta Medical Eye Center. He practiced there for seven years before founding Georgia Eye Partners. He currently performs surgery at Saint Joseph’s Hospital, Northside Hospital, Crawford Long Hospital, and Atlanta Outpatient Surgery Center. He currently serves as Assistant Clinical Professor of Ophthalmology at Emory University and Medical Director of TLC Vision Laser Center in Atlanta. He is Chief of the Division of Ophthalmology at St. Joseph’s Hospital and a past member of the Georgia Society of Ophthalmology’s Leadership Council.
About Austin Medical Technologies, Inc./eyeDirecti(TM) (Brand)
Austin Medical Technologies delivers “DIRECT” from the manufacturer to the Surgeon, the only technology based, “Single Source Supply Solution” for custom sterile surgery trays made up of 80% of all disposable surgical devices utilized in surgery. Currently the company has contracted with nearly 200 eye surgery centers including the 2 largest eye surgery centers in the USA. The market for custom sterile surgery trays is a $2.1 Billion market here in the USA.
Austin Medical is dedicated exclusively to the Ambulatory Surgery Center (ASC) market. Ambulatory Surgery Centers (ASC), also called outpatient surgery, and same-day surgery, refers to surgical procedures which are complex enough to require a dedicated operating room and specially trained staff, but do not require an overnight stay. According to 1996 U.S. government statistics, ambulatory surgery centers account for 31 million or 44% of the total surgeries performed in the United States. Five million surgeries were performed on eyes. New surgical techniques such as laser surgery allow procedures to be done more quickly and/or with less surgical trauma.
Under the brand name eyeDirecti, Austin Medical is initially focused on Ophthalmology owned and operated surgery centers which is the fastest growing segment of the ASC market, growing by 25% per annum, consisting of 2,500 practices with 15,000 surgeons performing over 5 million surgical procedures annually at a supply cost of $400,000,000 per year. Austin Medical is positioned to capture $40,000,000 (10%) of this $400,000,000 market within the next 4 years. Visit our e-commerce site at http://www.eyedirecti.com/
Note: Any statements released by Austin Medical Technologies, Inc., or any of its affiliates that are forward-looking, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act. Editors and investors are cautioned that forward-looking statements invoke risk and uncertainties that may affect the Company’s business prospects and performances. These include economic, competitive, governmental, technological and other factors discussed in the statements and in the Company’s filings with the Securities and Exchange Commission.
Austin Medical Technologies, Inc.
CONTACT: Keith Tarter of Austin Medical Technologies, Inc.,+1-972-370-0197, or investors@austinmedtech.com
